Iovance Biotherapeutics's Options Frenzy: What You Need to Know

Comments
Loading...

Whales with a lot of money to spend have taken a noticeably bullish stance on Iovance Biotherapeutics.

Looking at options history for Iovance Biotherapeutics IOVA we detected 8 trades.

If we consider the specifics of each trade, it is accurate to state that 62% of the investors opened trades with bullish expectations and 37% with bearish.

From the overall spotted trades, 5 are puts, for a total amount of $248,760 and 3, calls, for a total amount of $337,165.

Expected Price Movements

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $4.0 and $10.0 for Iovance Biotherapeutics, spanning the last three months.

Insights into Volume & Open Interest

In terms of liquidity and interest, the mean open interest for Iovance Biotherapeutics options trades today is 5176.0 with a total volume of 3,968.00.

In the following chart, we are able to follow the development of volume and open interest of call and put options for Iovance Biotherapeutics's big money trades within a strike price range of $4.0 to $10.0 over the last 30 days.

Iovance Biotherapeutics 30-Day Option Volume & Interest Snapshot

Options Call Chart

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
IOVA CALL TRADE BEARISH 03/15/24 $9.00 $278.4K 14.7K 2.0K
IOVA PUT TRADE BULLISH 09/20/24 $10.00 $80.0K 4 100
IOVA PUT SWEEP BEARISH 06/21/24 $9.00 $62.0K 339 200
IOVA PUT SWEEP BULLISH 09/20/24 $10.00 $40.0K 4 100
IOVA PUT SWEEP BEARISH 03/15/24 $4.00 $37.2K 4.5K 1.0K

About Iovance Biotherapeutics

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approval and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

In light of the recent options history for Iovance Biotherapeutics, it's now appropriate to focus on the company itself. We aim to explore its current performance.

Iovance Biotherapeutics's Current Market Status

  • Currently trading with a volume of 2,227,289, the IOVA's price is up by 1.81%, now at $7.87.
  • RSI readings suggest the stock is currently may be approaching overbought.
  • Anticipated earnings release is in 26 days.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Iovance Biotherapeutics, Benzinga Pro gives you real-time options trades alerts.

Market News and Data brought to you by Benzinga APIs
Date of Trade
ticker
Put/Call
Strike Price
DTE
Sentiment

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!